PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 2.92M (Avg.)
-0.48 | -4.19
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
877.13%
Revenue growth above 1.5x WEED.TO's 44.84%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
177.09%
Positive gross profit growth while WEED.TO is negative. John Neff would see a clear operational edge over the competitor.
-20.78%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-20.78%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
83.07%
Positive net income growth while WEED.TO is negative. John Neff might see a big relative performance advantage.
83.25%
Positive EPS growth while WEED.TO is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
83.25%
Positive diluted EPS growth while WEED.TO is negative. John Neff might view this as a strong relative advantage in controlling dilution.
0.59%
Share reduction more than 1.5x WEED.TO's 7.15%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.59%
Diluted share reduction more than 1.5x WEED.TO's 11.04%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
No Data
No Data available this quarter, please select a different quarter.
54.66%
OCF growth at 75-90% of WEED.TO's 68.75%. Bill Ackman would demand better working capital management or cost discipline.
39.94%
FCF growth 50-75% of WEED.TO's 68.24%. Martin Whitman would see if structural disadvantages exist in generating free cash.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-1466.81%
Negative 10Y OCF/share CAGR while WEED.TO stands at 26.30%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-1466.81%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-1466.81%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-86.27%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-86.27%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-86.27%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
147.79%
Below 50% of WEED.TO's 435.93%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
147.79%
5Y equity/share CAGR 1.25-1.5x WEED.TO's 122.19%. Bruce Berkowitz confirms if reinvested profits or buybacks explain the superior buildup.
147.79%
3Y equity/share CAGR similar to WEED.TO's 143.44%. Walter Schloss sees both having parallel profitability or reinvestment over 3 years.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
76.22%
AR growth well above WEED.TO's 33.25%. Michael Burry fears inflated revenue or higher default risk in the near future.
92.35%
We show growth while WEED.TO is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
-0.72%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-2.67%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-68.21%
We cut SG&A while WEED.TO invests at 41.19%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.